Patterns of anticoagulation therapy in atrial fibrillation: results from a large real-life single-center registry.
CONCLUSION: Warfarin and DOACs are administered to different target populations, possibly due to socio-economic reasons. Patients receiving warfarin rarely obtain optimal dosing control, and experience significantly shorter survival compared with patients receiving DOACs.
PMID: 33150762 [PubMed - in process]
Source: Croatian Medical Journal - Category: General Medicine Authors: Jurin I, Lucijanić M, Šakić Z, Hulak Karlak V, Atić A, Magličić A, Starčević B, Hadžibegović I Tags: Croat Med J Source Type: research
More News: Atrial Fibrillation | Bleeding | Brain | Coumadin | Croatia Health | General Medicine | Neurology | Pradaxa | Stroke | Thrombosis | Warfarin